Label: MAXIMUM STRENGTH SENNA LAXATIVE- sennoside 25 mg tablet

  • NDC Code(s): 72090-016-01
  • Packager: Pioneer Life Sciences, LLC
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated March 10, 2025

If you are a consumer or patient please visit this version.

  • Active Ingredient (in each tablet)

    Sennosides 25 mg

  • Purpose

    Stimulant Laxative

  • Uses:

    • relieves occasional constipation (irregularity).
    • generally prodcues a bowel movement in 6-12 hours
  • Warnings:

    Do not use

    • laxative products when abdominal pain, nausea, or vomiting are present unless directed by a doctor
  • ASK DOCTOR

    Ask a doctor before use if you have

    • noticed a sudden change in bowel habits that persists over a period of 2 weeks.

    Ask a doctor or pharmacist before use if you

    • are taking any other drug. Laxatives may affect how other drugs work. Take this product 2 or more hours before or after other drugs.
  • WHEN USING

    When using this product

    • do not use for a period longer than 1 week
  • STOP USE

    Stop use and ask a doctor if
    rectal bleeding or failure to have a bowel movement occur after use of a laxative. These may be signs of a serious condition.

  • PREGNANCY OR BREAST FEEDING

    If pregnant or breast-feeding, ask a health professional before use.

  • KEEP OUT OF REACH OF CHILDREN

    KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away. 

  • DIRECTIONS

    • swallow tablet (s) with a glass of water.
    • swallow tablet (s) whole, do not crush, break or chew.
    • adults and children 12 years of age and older: 2 tablets once or twice daily
    • children 6 to under 12 years of age: 1 tablet once or twice daily
    • children under 6 years of age: ask a doctor
  • OTHER INFORMATION

    • each tablet contains: Calcium 27 mg, Magnesium 0.16 mg, Sodium 0.81 mg  
    • store at controlled room temperature 20-25°C (68-77°F) 
  • INACTIVE INGREDIENTS

    Microcrystalline Cellulose, Dicalcium Phosphate/Dibasic Calcium Phosphate, Croscarmellose Sodium, Sodium Lauryl sulphate, Colloidal Silicon Dioxide, Crospovidone, Stearic acid powder, Magnesium Stearate, Brilliant Blue Lake, Indigo Carmine Lake, Polyvinly Alcohol, Polyethylene Glycol, Titanium Dioxide, Talc

  • QUESTIONS OR COMMENTS?

    Call 1-732-698-5070 Monday through Friday 9 am to 5 pm EST or visit: www.gencare.health

  • NDC 72090-016-01 (100ct Bottle)

    PL0153-02 - GenCare Generic Laxative 100ct-Elysium

  • INGREDIENTS AND APPEARANCE
    MAXIMUM STRENGTH SENNA LAXATIVE 
    sennoside 25 mg tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72090-016
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES25 mg
    Inactive Ingredients
    Ingredient NameStrength
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J)  
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    CROSPOVIDONE, UNSPECIFIED (UNII: 2S7830E561)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
    INDIGOTINDISULFONATE SODIUM (UNII: D3741U8K7L)  
    POLYVINYL ALCOHOL (UNII: 532B59J990)  
    POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    TALC (UNII: 7SEV7J4R1U)  
    Product Characteristics
    Colorblue (Light Blue) Scoreno score
    ShapeROUND (Biconvex) Size11mm
    FlavorImprint Code S3
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:72090-016-01100 in 1 BOTTLE; Type 0: Not a Combination Product03/06/2025
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph Drug505G(a)(3)03/06/2025
    Labeler - Pioneer Life Sciences, LLC (014092742)
    Registrant - Pioneer Life Sciences, LLC (014092742)